Crossref
Population-based Prevalence of Bronchiectasis in the United States
CHEST · 2026-10
DOI: 10.1016/j.chest.2026.10.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2026-10. Verfasst von Author List Kristy Iglay und 6 weiteren Autor:innen. Beteiligte Einrichtung: CERobs Consulting LLC, Asheville, NC, USA. Gefördert von: Boehringer Ingelheim GmbH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
bronchiectasiscystic fibrosisobservationalpaediatricprevalence
Autor:innen und Institutionen
- CERobs Consulting LLC, Asheville, NC, USA.
- Medical University of South Carolina, Charleston, SC, USA.
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
- Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
- Medical University of South Carolina, Charleston, SC, USA. Electronic address: flumepa@musc.edu.
Förderung
- Boehringer Ingelheim GmbH
Zitieren
APA
Iglay, A. L. K., Mingora, C. M., Mountford, W. K., Zhang, L., Engel, A. T., Olson, A. L., & Flume, P. A. (2026). Population-based Prevalence of Bronchiectasis in the United States. CHEST. https://doi.org/10.1016/j.chest.2026.10.031
Vancouver
Iglay ALK, Mingora CM, Mountford WK, Zhang L, Engel AT, Olson AL, et al. Population-based Prevalence of Bronchiectasis in the United States. CHEST. 2026. doi:10.1016/j.chest.2026.10.031
BibTeX
@article{Iglay2026,
author = {Iglay, Author List Kristy and Mingora, Christina M and Mountford, William K and Zhang, Lu and Engel, Annemarie T and Olson, Amy L and Flume, Patrick A},
title = {Population-based Prevalence of Bronchiectasis in the United States},
journal = {CHEST},
year = {2026},
doi = {10.1016/j.chest.2026.10.031}
}
EUVIMED